TGFB1 and diabetic kidney disease: reported that Sestrin2 remedies podocyte injury in DKD through the coordination with TSP-1/TGF-β1/Smad3 pathway, suggesting that Sestrin2/TSP-1/TGF-β1 signaling is critically involved in renal protection (22).